Allen Brinker

1.9k total citations
41 papers, 1.2k citations indexed

About

Allen Brinker is a scholar working on Surgery, Pharmacology and Pharmacology. According to data from OpenAlex, Allen Brinker has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 7 papers in Pharmacology and 6 papers in Pharmacology. Recurrent topics in Allen Brinker's work include Multiple Sclerosis Research Studies (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Allen Brinker is often cited by papers focused on Multiple Sclerosis Research Studies (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Allen Brinker collaborates with scholars based in United States, Thailand and Germany. Allen Brinker's co-authors include Mark Avigan, Julie Beitz, Cindy Kortepeter, Carol Pamer, Peter K. Honig, Jerry L. Phillips, S. Christopher Jones, David Croteau, Parivash Nourjah and Syed Rizwanuddin Ahmad and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and Hepatology.

In The Last Decade

Allen Brinker

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allen Brinker United States 16 231 188 187 177 166 41 1.2k
Eric N. van Roon Netherlands 25 255 1.1× 90 0.5× 159 0.9× 247 1.4× 640 3.9× 92 2.0k
Emilio Vargas Spain 24 155 0.7× 90 0.5× 142 0.8× 101 0.6× 376 2.3× 102 2.5k
Rita Schinnar United States 21 277 1.2× 59 0.3× 262 1.4× 108 0.6× 318 1.9× 36 2.5k
Ghada Miremont‐Salamé France 22 148 0.6× 48 0.3× 331 1.8× 261 1.5× 118 0.7× 76 1.8k
Jung Mi Oh South Korea 24 91 0.4× 39 0.2× 130 0.7× 139 0.8× 215 1.3× 139 1.7k
Che‐Yi Chou Taiwan 26 258 1.1× 103 0.5× 33 0.2× 80 0.5× 373 2.2× 127 1.9k
Françoise Haramburu France 30 238 1.0× 74 0.4× 605 3.2× 417 2.4× 137 0.8× 129 2.7k
Curtis A. Johnson United States 21 129 0.6× 176 0.9× 163 0.9× 43 0.2× 157 0.9× 68 1.3k
A.‐P. Jonville‐Béra France 24 164 0.7× 40 0.2× 260 1.4× 137 0.8× 259 1.6× 136 1.8k
Tiansheng Wang United States 27 235 1.0× 41 0.2× 272 1.5× 65 0.4× 355 2.1× 96 2.0k

Countries citing papers authored by Allen Brinker

Since Specialization
Citations

This map shows the geographic impact of Allen Brinker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allen Brinker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allen Brinker more than expected).

Fields of papers citing papers by Allen Brinker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allen Brinker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allen Brinker. The network helps show where Allen Brinker may publish in the future.

Co-authorship network of co-authors of Allen Brinker

This figure shows the co-authorship network connecting the top 25 collaborators of Allen Brinker. A scholar is included among the top collaborators of Allen Brinker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allen Brinker. Allen Brinker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Tiffany, et al.. (2025). Anaphylaxis and glatiramer acetate. Multiple Sclerosis Journal. 31(14). 1664–1671.
2.
Croteau, David, Tiffany Kim, J. Clarke Stevens, et al.. (2024). Progressive multifocal leukoencephalopathy associated with sphingosine-1-phosphate receptor modulators: A large case series. Multiple Sclerosis and Related Disorders. 92. 106163–106163.
3.
Kim, Tiffany, Allen Brinker, David Croteau, et al.. (2023). Immune-mediated colitis associated with ocrelizumab: A new safety risk. Multiple Sclerosis Journal. 29(10). 1275–1281. 9 indexed citations
4.
Kim, Tiffany, David Croteau, Allen Brinker, et al.. (2020). Expanding spectrum of opportunistic infections associated with dimethyl fumarate. Multiple Sclerosis Journal. 27(8). 1301–1305. 5 indexed citations
5.
Kim, Tiffany, et al.. (2019). Hemophagocytic lymphohistiocytosis associated with the use of lamotrigine. Neurology. 92(21). e2401–e2405. 12 indexed citations
6.
Brinker, Allen, et al.. (2017). Etonogestrel implant migration to the vasculature, chest wall, and distant body sites: cases from a pharmacovigilance database. Contraception. 96(6). 439–445. 24 indexed citations
7.
Grenade, Lois La, et al.. (2016). Chemical Leukoderma Associated with Methylphenidate Transdermal System: Data From the US Food and Drug Administration Adverse Event Reporting System. The Journal of Pediatrics. 180. 241–246. 6 indexed citations
8.
Lauer, Wolfgang, et al.. (2014). Medizinprodukte. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 57(12). 1355–1361. 3 indexed citations
9.
Brinker, Allen, et al.. (2013). Spontaneous Reports of Seizure in Association With Leuprolide (Lupron Depot), Goserelin (Zoladex Implant), and Naferelin (Synarel Nasal Spray). Obstetrics and Gynecology. 121(5). 1107–1107. 3 indexed citations
10.
11.
Brinker, Allen, et al.. (2011). Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients. Journal of the American Academy of Dermatology. 65(3). 546–551. 95 indexed citations
12.
Brinker, Allen, Andrew D. Mosholder, Stephanie D. Schech, Margaret Burgess, & Mark Avigan. (2007). Indication and Use of Drug Products Used to Treat Attention-Deficit/Hyperactivity Disorder: A Cross-Sectional Study with Inference on the Likelihood of Treatment in Adulthood. Journal of Child and Adolescent Psychopharmacology. 17(3). 328–333. 8 indexed citations
13.
Brinker, Allen, Stephanie D. Schech, Margaret Burgess, & Mark Avigan. (2007). An Observational Study of Cholecystectomy in Patients Receiving Tegaserod. Drug Safety. 30(7). 581–588. 2 indexed citations
14.
Schech, Stephanie D., Allen Brinker, Deborah Shatin, & Margaret Burgess. (2006). New‐onset and idiopathic thrombotic thrombocytopenic purpura: Incidence, diagnostic validity, and potential risk factors. American Journal of Hematology. 81(9). 657–663. 5 indexed citations
15.
Grenade, Lois La, Lauren Lee, Joyce Weaver, et al.. (2005). Comparison of Reporting of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Selective COX-2 Inhibitors. Drug Safety. 28(10). 917–924. 59 indexed citations
16.
Brinker, Allen, Lawrence Goldkind, Renan A. Bonnel, & Julie Beitz. (2004). Spontaneous Reports of Hypertension Leading to Hospitalisation in Association with Rofecoxib, Celecoxib, Nabumetone and Oxaprozin. Drugs & Aging. 21(7). 479–484. 19 indexed citations
17.
Brinker, Allen, Carol Pamer, & Julie Beitz. (2003). Changes in Ciprofloxacin Utilization as Shown in a Large Pharmacy Claims Database: Effects of Proximity to Criminal Anthrax Exposure in October 2001. Journal of the American Pharmacists Association. 43(3). 375–378. 6 indexed citations
18.
Ahmad, Syed Rizwanuddin, Cindy Kortepeter, Allen Brinker, Min Chen, & Julie Beitz. (2002). Renal Failure Associated with the Use of Celecoxib and Rofecoxib. Drug Safety. 25(7). 537–544. 85 indexed citations
19.
Brinker, Allen & Julie Beitz. (2002). Spontaneous reports of thrombocytopenia in association with quinine: Clinical attributes and timing related to regulatory action. American Journal of Hematology. 70(4). 313–317. 26 indexed citations
20.
Häuser, I., et al.. (1997). Effect of cyclosporine intervariability on the long-term outcome of renal transplantation. Transplantation Proceedings. 29(1-2). 274–274. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric N. van Roon Breakdown of academic impact, for papers by Emilio Vargas Breakdown of academic impact, for papers by Rita Schinnar Breakdown of academic impact, for papers by Ghada Miremont‐Salamé Breakdown of academic impact, for papers by Jung Mi Oh Breakdown of academic impact, for papers by Che‐Yi Chou Breakdown of academic impact, for papers by Françoise Haramburu Breakdown of academic impact, for papers by Curtis A. Johnson Breakdown of academic impact, for papers by A.‐P. Jonville‐Béra Breakdown of academic impact, for papers by Tiansheng Wang
Rankless by CCL
2026